ArticleVirchows Archiv : an international journal of pathology2026
Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Keratins (CK) and desmosomal proteins are associated with prognosis in many cancers, and CK5, CK14 and CK20 are recognized as surrogate markers for molecular subtyping of muscle-invasive bladder cancer (MIBC). We analyzed the correlation between protein clustering and MIBC subtypes. We retrieved samples of muscle-invasive UC from patients treated with radical cystectomy without prior neoadjuvant therapy at two institutions. Immunohistochemical staining with tissue microarrays was performed for keratins (CK5, CK7, CK8, CK10, CK13, CK14, CK17, CK18, CK19, CK20), desmogleins (DSG2, DSG3) and desmocollin 3 (DSC3), and outcomes were evaluated using the H-Score. Molecular classification subgroups were defined according to CK5 and CK20 expression; for a subset of cases, the MDACC molecular classification was also available. Clinical data were retrieved from medical records. Hierarchical clustering with Euclidean distance, classification trees and principal component analysis was used for data visualization. We identified protein clustering patterns for luminal and basal subtypes in 232 analyzed samples. DSG2 groups were independent from DSC3 and DSG3 clustering in the luminal subtype. The molecular clusters were comparable in matched primary tumour and lymph node metastases (LNM) samples, and the protein expression correlated moderately with each other. CK5 (PT (90 [IQR 8.3-265, LNM (30.8 [IQR 6.7-155]; p = 0.011)), CK17 (PT (145 [IQR 42.5-222.5]),LNM (47.5 [IQR 14.2-110]; p = 0.005), DSG2 ( PT (55 [IQR 15-105]), LNM (32.1 (7.5-75.8)); p = 0.004), and DSC3 (PT (20.8 [IQR 0-71.7]), LNM (3.8 [IQR 0-43.3]; p = 0.013) expression were lower in LNM. Limitations include the absence of patients treated with neoadjuvant therapy and the risk of overfitting. We concluded that distinct keratin and desmosomal protein patterns are linked to cancer subtypes, and remain consistent in LNM. These findings indicate potential for keratins and desmosomal proteins to guide muscle-invasive bladder cancer subtype classification with possible prognostic implications, necessitating further research.
Indexed as
Identifiers
42406031What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.